Anti-Hu negative | Anti-Hu positive | |
---|---|---|
Number of patients | 43 | 9 |
Metastases at initial screening: | ||
Brain | 8/43 (19%) | 0/82-150 |
Epidural | 1/43 (2%) | 0/82-150 |
Leptomeningal | 0/43 | 0/82-150 |
Adrenal | 2/43 (5%) | 0/9 |
Bone marrow | 6/43 (14%) | 0/9 |
Bone | 18/43 (42%) | 5/9 (56%) |
Liver | 10/43 (23%) | 3/9 (33%) |
Other | 6/43 (14%) | 1/9 (11%) |
Any metastasis | 30/43 (70%) | 5/9 (56%) |
Metastases at follow up | ||
Brain metastases | 18/43 (42%) | 5/9 (56%) |
Leptomeningal metastases | 2/43 (5%) | 0/9 |
Epidural metastases | 3/43 (7%) | 1/9 (11%) |
↵2-150 One patient had no MRI.